Advancing rheumatoid arthritis synovial biopsy analysis: one B cell at a time.
While biologic therapies have dramatically improved the management of rheumatoid arthritis (RA), not all patients respond well to treatment and the field continues to await individualized medicine approaches that promise to determine effective medications based on a patient's distinct disease features. The cellular and molecular characterization of an individual's synovium holds promise to understand pathology, predict outcomes and tailor treatment decisions, akin to the histologic and genetic assessment of tumor tissue that guides cancer care.